Tryptamine → 1-Indan-5-yl-2,3,4,9-tetrahydro-1H-beta-carboline

HRID 381473Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 381473
[NH2:1][CH2:2][CH2:3][C:4]1[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[NH:6][CH:5]=1.[CH2:13]1[C:21]2[C:16](=[CH:17][C:18]([CH:22]=O)=[CH:19][CH:20]=2)[CH2:15][CH2:14]1.C(O)(C(F)(F)F)=O>>[CH2:13]1[C:21]2[C:16](=[CH:17][C:18]([CH:22]3[C:5]4[NH:6][C:7]5[C:12](=[CH:11][CH:10]=[CH:9][CH:8]=5)[C:4]=4[CH2:3][CH2:2][NH:1]3)=[CH:19][CH:20]=2)[CH2:15][CH2:14]1

Komponenten

4

Edukt 3

HCID 1150TryptamineHCID 6422Trifluoroacetic acidHCID 1216245-Indanecarboxaldehyde

Produkt 1

HCID 108807391-Indan-5-yl-2,3,4,9-tetrahydro-1H-beta-carbolineAusbeute 15,6 %

Versuchsvorschrift

This product was prepared using the same procedure as for Intermediate 1 with tryptamine (1.28 g, 8.0 mmol), indan-5-carboxaldehyde (1.3 g, 1.1 equiv.) and TFA (1.2 mL, 2 equiv.) to give the title compound (0.36 g, 14%).

Aufarbeitung

  1. customThis product was prepared

Quellen und Nachweise

ORD-Eintrag
ord-407958afdb2346f3baf4dbeda805a3ed
Quelldatensatz
uspto-grants-2001_10
Patentnummer
US06306870B1

Notizen zur Reaktion

Wird geladen…